Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 23 studies | 34% ± 13% | |
astrocyte | 16 studies | 38% ± 19% | |
oligodendrocyte precursor cell | 13 studies | 39% ± 18% | |
ciliated cell | 12 studies | 31% ± 15% | |
microglial cell | 12 studies | 33% ± 13% | |
fibroblast | 12 studies | 33% ± 12% | |
oligodendrocyte | 12 studies | 36% ± 14% | |
GABAergic neuron | 10 studies | 46% ± 23% | |
macrophage | 10 studies | 30% ± 11% | |
glutamatergic neuron | 9 studies | 53% ± 24% | |
adipocyte | 9 studies | 35% ± 12% | |
epithelial cell | 8 studies | 34% ± 13% | |
pericyte | 7 studies | 28% ± 7% | |
endothelial cell of lymphatic vessel | 7 studies | 41% ± 8% | |
smooth muscle cell | 7 studies | 28% ± 8% | |
interneuron | 6 studies | 53% ± 20% | |
T cell | 6 studies | 28% ± 10% | |
club cell | 6 studies | 35% ± 16% | |
basal cell | 6 studies | 37% ± 17% | |
B cell | 5 studies | 23% ± 10% | |
neuron | 5 studies | 47% ± 19% | |
cardiac muscle cell | 5 studies | 33% ± 9% | |
type I pneumocyte | 5 studies | 40% ± 6% | |
type II pneumocyte | 5 studies | 49% ± 7% | |
natural killer cell | 4 studies | 23% ± 6% | |
granule cell | 4 studies | 30% ± 7% | |
CD4-positive, alpha-beta T cell | 4 studies | 20% ± 5% | |
mast cell | 4 studies | 24% ± 6% | |
amacrine cell | 4 studies | 29% ± 5% | |
retina horizontal cell | 4 studies | 31% ± 7% | |
retinal cone cell | 4 studies | 30% ± 7% | |
retinal rod cell | 4 studies | 34% ± 5% | |
monocyte | 4 studies | 29% ± 8% | |
GABAergic interneuron | 3 studies | 34% ± 4% | |
progenitor cell | 3 studies | 32% ± 3% | |
CD8-positive, alpha-beta T cell | 3 studies | 19% ± 5% | |
dendritic cell | 3 studies | 21% ± 4% | |
mesothelial cell | 3 studies | 37% ± 16% | |
vein endothelial cell | 3 studies | 30% ± 14% | |
GABAergic amacrine cell | 3 studies | 30% ± 7% | |
Mueller cell | 3 studies | 32% ± 9% | |
glycinergic amacrine cell | 3 studies | 31% ± 6% | |
retinal ganglion cell | 3 studies | 24% ± 6% | |
myeloid cell | 3 studies | 26% ± 3% | |
endothelial cell of vascular tree | 3 studies | 34% ± 10% | |
hepatocyte | 3 studies | 52% ± 15% | |
connective tissue cell | 3 studies | 27% ± 8% | |
ependymal cell | 3 studies | 50% ± 14% | |
alveolar macrophage | 3 studies | 27% ± 7% | |
respiratory goblet cell | 3 studies | 39% ± 14% | |
lymphocyte | 3 studies | 34% ± 5% | |
goblet cell | 3 studies | 41% ± 27% | |
transit amplifying cell | 3 studies | 33% ± 22% | |
mucus secreting cell | 3 studies | 33% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 100% | 1019.27 | 578 / 578 | 100% | 15.43 | 1155 / 1155 |
esophagus | 100% | 833.20 | 1444 / 1445 | 100% | 14.63 | 183 / 183 |
prostate | 100% | 1219.92 | 245 / 245 | 100% | 15.50 | 500 / 502 |
breast | 100% | 1284.12 | 459 / 459 | 100% | 18.08 | 1113 / 1118 |
thymus | 100% | 1772.32 | 653 / 653 | 100% | 24.08 | 602 / 605 |
bladder | 100% | 1179.24 | 21 / 21 | 99% | 14.92 | 497 / 504 |
stomach | 100% | 648.04 | 359 / 359 | 99% | 15.87 | 282 / 286 |
pancreas | 99% | 462.90 | 325 / 328 | 99% | 14.98 | 177 / 178 |
brain | 98% | 509.14 | 2602 / 2642 | 100% | 10.91 | 704 / 705 |
ovary | 100% | 1426.02 | 180 / 180 | 98% | 9.68 | 422 / 430 |
uterus | 100% | 1348.73 | 170 / 170 | 98% | 15.91 | 449 / 459 |
intestine | 100% | 937.86 | 966 / 966 | 97% | 16.78 | 511 / 527 |
kidney | 100% | 821.98 | 89 / 89 | 96% | 12.14 | 863 / 901 |
adrenal gland | 100% | 761.30 | 258 / 258 | 93% | 10.84 | 215 / 230 |
liver | 100% | 502.64 | 226 / 226 | 87% | 6.50 | 352 / 406 |
skin | 100% | 996.20 | 1805 / 1809 | 85% | 12.90 | 400 / 472 |
adipose | 100% | 1193.27 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1084.79 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 9.68 | 29 / 29 |
spleen | 100% | 756.17 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 8.40 | 1 / 1 |
muscle | 99% | 600.24 | 797 / 803 | 0% | 0 | 0 / 0 |
heart | 98% | 659.13 | 845 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 11.34 | 44 / 45 |
peripheral blood | 52% | 368.22 | 486 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 45% | 3.75 | 36 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0042531 | Biological process | positive regulation of tyrosine phosphorylation of STAT protein |
GO_1905515 | Biological process | non-motile cilium assembly |
GO_0060271 | Biological process | cilium assembly |
GO_0002376 | Biological process | immune system process |
GO_0042976 | Biological process | activation of Janus kinase activity |
GO_0071539 | Biological process | protein localization to centrosome |
GO_0032695 | Biological process | negative regulation of interleukin-12 production |
GO_0032733 | Biological process | positive regulation of interleukin-10 production |
GO_0090307 | Biological process | mitotic spindle assembly |
GO_0032815 | Biological process | negative regulation of natural killer cell activation |
GO_0007080 | Biological process | mitotic metaphase chromosome alignment |
GO_0031393 | Biological process | negative regulation of prostaglandin biosynthetic process |
GO_0042532 | Biological process | negative regulation of tyrosine phosphorylation of STAT protein |
GO_0005615 | Cellular component | extracellular space |
GO_0034451 | Cellular component | centriolar satellite |
GO_0005813 | Cellular component | centrosome |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0005136 | Molecular function | interleukin-4 receptor binding |
GO_0005515 | Molecular function | protein binding |
Gene name | PIBF1 |
Protein name | PIBF1 protein Progesterone-induced-blocking factor 1 (PIBF) (Centrosomal protein of 90 kDa) (CEP90) Progesterone immunomodulatory binding factor 1 |
Synonyms | PIBF C13orf24 |
Description | FUNCTION: Plays a role in ciliogenesis. .; FUNCTION: [Isoform 1]: Pericentriolar protein required to maintain mitotic spindle pole integrity . Required for the centrosomal accumulation of PCM1 and the recruitment of centriolar satellite proteins such as BBS4. Via association with PCM1 may be involved in primary cilia formation . Required for CEP63 centrosomal localization and its interaction with WDR62. Together with CEP63 promotes centriole duplication. Promotes the centrosomal localization of CDK2 . .; FUNCTION: [Isoform 4]: The secreted form is a mediator of progesterone that by acting on the phospholipase A2 enzyme interferes with arachidonic acid metabolism, induces a Th2 biased immune response, and by controlling decidual naturakl killer cells (NK) activity exerts an anti-abortive effect . Increases the production of Th2-type cytokines by signaling via the JAK/STAT pathway. Activates STAT6 and inhibits STAT4 phosphorylation. Signaling via a not identified receptor seems to implicate IL4R and a GPI-anchored protein . . |
Accessions | Q4G0R1 A0A087WUI6 ENST00000617689.4 Q05DN0 ENST00000615625.1 [Q8WXW3-2] Q8WXW3 ENST00000326291.11 [Q8WXW3-1] |